Clinical Trial Update: Phase 4 Study - Mucinex D as Adjunct Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Mucinex D as adjunct therapy for acute respiratory infection, bronchitis, and rhinosinusitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Respiratory Infection
• Rhinosinusitis

Drugs mentioned

• Mucinex D

Snippet

Sponsor: Adams Respiratory Therapeutics | Conditions: Acute Respiratory Infection, Bronchitis | Phase 4 | Status: COMPLETED